Autonomous Healthcare
Autonomous Healthcare is dedicated to improving the quality of care through automation, developing next-generation automated medical technologies. Founded by a team of aerospace engineers with training in biomedicine, the company focuses on innovative solutions such as AI-enabled software for mechanical ventilation management, semi-automated and fully-automated hemodynamic management, and health monitoring for astronauts. Their work includes advanced control algorithms, space exploration health tech, and ICU automation, aiming to revolutionize critical care and space health monitoring.
Industries
Nr. of Employees
small (1-50)
Autonomous Healthcare
Patents
Clinical decision support system for patient-ventilator asynchrony detection and management
US-12194237-B2
View DetailsHierarchical adaptive closed-loop fluid resuscitation and cardiovascular drug administration system
US-11707571-B2
View DetailsHierarchical adaptive closed-loop fluid resuscitation and cardiovascular drug administration system
US-11338087-B2
View DetailsClinical decision support system for patient-ventilator asynchrony detection and management
US-11000656-B2
View DetailsHierarchical adaptive closed-loop fluid resuscitation and cardiovascular drug administration system
US-10926031-B2
View DetailsClinical decision support system for patient-ventilator asynchrony detection and management
US-10874811-B2
View Details
Clinical decision support system for patient-ventilator asynchrony detection and management
US-12194237-B2
View DetailsHierarchical adaptive closed-loop fluid resuscitation and cardiovascular drug administration system
US-11707571-B2
View DetailsHierarchical adaptive closed-loop fluid resuscitation and cardiovascular drug administration system
US-11338087-B2
View DetailsClinical decision support system for patient-ventilator asynchrony detection and management
US-11000656-B2
View DetailsHierarchical adaptive closed-loop fluid resuscitation and cardiovascular drug administration system
US-10926031-B2
View DetailsClinical decision support system for patient-ventilator asynchrony detection and management
US-10874811-B2
View DetailsProducts
Syncron-E
AI-based software that analyzes pressure and flow waveforms in real time to detect patient–ventilator asynchrony and ineffective triggering.
E-Fusion
Smart fluid and vasoactive drug management system capable of providing semi-automated clinical decision support and fully-automated closed-loop fluid and drug management.
Countra
Closed-loop system for managing dispensing, use, transfer, and wasting of controlled substances in ambulatory surgery centers and clinics, combining tamper‑proof ledger technology and AI for diversion monitoring.
AstroSight
Computer vision–based video analytics and non-invasive vital sign monitoring technology developed for astronaut health monitoring in space missions.
Syncron-E™
An artificial intelligence-based software technology that analyzes pressure and flow waveforms in real-time to detect various types of patient-ventilator asynchrony.
AstroSight™
A computer vision-based technology providing video analytics and non-invasive vital sign monitoring, developed under contract with NASA for astronauts during space exploration missions.
Syncron-E
AI-based software that analyzes pressure and flow waveforms in real time to detect patient–ventilator asynchrony and ineffective triggering.
E-Fusion
Smart fluid and vasoactive drug management system capable of providing semi-automated clinical decision support and fully-automated closed-loop fluid and drug management.
Countra
Closed-loop system for managing dispensing, use, transfer, and wasting of controlled substances in ambulatory surgery centers and clinics, combining tamper‑proof ledger technology and AI for diversion monitoring.
AstroSight
Computer vision–based video analytics and non-invasive vital sign monitoring technology developed for astronaut health monitoring in space missions.
Syncron-E™
An artificial intelligence-based software technology that analyzes pressure and flow waveforms in real-time to detect various types of patient-ventilator asynchrony.
AstroSight™
A computer vision-based technology providing video analytics and non-invasive vital sign monitoring, developed under contract with NASA for astronauts during space exploration missions.
Services
Developing investigational monitoring and automation technologies under sponsored contracts for agencies including NASA, DARPA, NIH and other federal sponsors.
Design and execution of animal-model studies and retrospective/clinical validation to assess algorithm sensitivity and performance metrics.
Developing investigational monitoring and automation technologies under sponsored contracts for agencies including NASA, DARPA, NIH and other federal sponsors.
Design and execution of animal-model studies and retrospective/clinical validation to assess algorithm sensitivity and performance metrics.
Expertise Areas
- Mechanical ventilation management
- Closed-loop fluid resuscitation and vasoactive drug management
- Critical care automation and ICU workflow optimization
- AI-driven clinical decision support
Key Technologies
- Machine learning for physiological waveform analysis
- Adaptive closed-loop control systems
- Computer vision for vital-sign extraction
- Video-based non-invasive vital sign monitoring
News & Updates
TraCS.AI technology can improve patient safety through AI-based drug management.
Autonomous Healthcare has been awarded a $750,000 contract to develop a non-invasive vital sign monitoring technology for astronauts.
The contract will support the development of a technology that will provide fully automated partial resuscitative endovascular balloon occlusion of the aorta.
Autonomous Healthcare’s Syncron-E™ technology for automated detection of patient-ventilator asynchrony is twice as sensitive in detecting ineffective triggering compared to clinicians.
Autonomous Healthcare has been awarded a $746,000 grant to further develop E-Fusion™.
Autonomous Healthcare was selected as a finalist in the 2017 MassChallenge Boston accelerator program.
TraCS.AI technology can improve patient safety through AI-based drug management.
Autonomous Healthcare has been awarded a $750,000 contract to develop a non-invasive vital sign monitoring technology for astronauts.
The contract will support the development of a technology that will provide fully automated partial resuscitative endovascular balloon occlusion of the aorta.
Autonomous Healthcare’s Syncron-E™ technology for automated detection of patient-ventilator asynchrony is twice as sensitive in detecting ineffective triggering compared to clinicians.
Autonomous Healthcare has been awarded a $746,000 grant to further develop E-Fusion™.
Autonomous Healthcare was selected as a finalist in the 2017 MassChallenge Boston accelerator program.